Pasithea Therapeutics Warrants
KTTAW
4 hedge funds and large institutions have $6.83K invested in Pasithea Therapeutics Warrants in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
11% less capital invested
Capital invested by funds: $7.72K → $6.83K (-$888)
20% less funds holding
Funds holding: 5 → 4 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$1.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$247 |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$207 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KC
1
Kepos Capital
New York
| $5K | – | – | – |
|
|
TSS
2
Two Sigma Securities
New York
| $784 | +$1.22K | +55,579 | New |
|
|
AC
3
Armistice Capital
New York
| $705 | – | – | – |
|
|
MG
4
Marex Group
London,
| $345 | – | – | – |
|
|
5
Citadel Advisors
Miami,
Florida
| – | -$207 | -15,191 | Closed |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$247 | -14,586 | Closed |
|
KTTAW Hedge Fund Activity: Q4 2025 in Review
4 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Pasithea Therapeutics Warrants (KTTAW) for Q4 2025, worth a combined $6.83K — down 11% from $7.72K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of KTTAW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $1.22K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $247 sold.
- 4 institutional investors held Pasithea Therapeutics Warrants (KTTAW) as of Q4 2025, down from 5 in Q3 2025.
- Funds reported $6.83K of Pasithea Therapeutics Warrants stock for Q4 2025, down 11% quarter-over-quarter.
- 1 fund opened new Pasithea Therapeutics Warrants positions in Q4 2025 and 2 closed out, a net change of -1 holder.
- The largest Pasithea Therapeutics Warrants buyer in Q4 2025 was Two Sigma Securities, an estimated $1.22K added.
- The largest Pasithea Therapeutics Warrants seller in Q4 2025 was Susquehanna International Group, an estimated $247 sold.
Based on aggregated 13F filings for Q4 2025.